NPM1 and acute myeloid leukemia: In AML patients, deletion/insertion mutations in NPM1 exon 12 (NPM1-DIM) change the C-terminal amino acids and impair the protein’s nucleocytoplasmic shuttling activity, causing disease pathogenesis [21].